Status:
COMPLETED
IPACK or Selective Tibial Nerve Block for ACL Reconstruction With an Adductor Canal Block
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Analgesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the analgesic efficacy of the combination of an adductor canal and selective tibial nerve blocks versus adductor canal block and IPACK after ACL reconstruction ...
Detailed Description
The hypothesis of this study is that a combined adductor canal and selective tibial nerve block provides better analgesia than a combined adductor canal block and IPACK in patients undergoing anterior...
Eligibility Criteria
Inclusion
- ASA score I-III
- 18 years or older
- Scheduled for elective primary ACL reconstruction
- Signature of consent form
Exclusion
- Refusal or inability for informed consent
- Known allergies to ropivacaine, acetaminophen, ibuprofen, ketorolac, morphine, sufentanyl, ondansetron or dexamethason
- Secondary surgical revision
- Opioid treatment such as morphine, hydrocodone, hydromorphone, tramadol, methadone, fentanyl, buprenorphine or codeine
- Bleeding diathesis
- Neurological deficit
- Known renal insufficiency (eGFR \<45 ml/min)
- Known hepatic insufficiency (Child score B or C)
- Pregnancy or lactating
- Alcohol abuse
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 14 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05303233
Start Date
May 1 2022
End Date
July 14 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Lausanne
Lausanne, Switzerland, 1011